Effectiveness of hemostatic agent during TKA

Effectiveness of hemostatic agent during TKA - Effectiveness of hemostatic agent during TKA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000053759

Enrollment

100

Registered

2024-04-01

Start date

2024-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee disease

Interventions

Intraoperative use of &quot

hemostatic agents,&quot

which are developed to stop bleeding from soft tissues during TKA surgery Intraoperative no use of &quot

which are developed to stop bleeding from soft tissues during TKA surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing TKA as usual

Exclusion criteria

Exclusion criteria: patients who rejected to participate this study

Design outcomes

Primary

Measure	Time frame
Estimated blood loss during perioperative TKA	—

Secondary

Measure	Time frame
Functional outcomes, swelling, or labo data	—

Countries

Japan

Contacts

Public ContactHideki Ueyama

Osaka Rosai Hospital Orthopedic surgery

ueyama.rosai@gmail.com+81-72-252-3561

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026